Correct your account

SUITE 220, 89 HIGH STREET
VIC 3101 MELBOURNE-KEW

phone +61(3) 9854 6230
fax 03 9853 5134
email virax@virax.com
www.virax.com.au

Short profile:

Australian biopharmaceutical, development company in immunotherapeutics for autoimmune diseases, AIDS, cancers, infectious diseases based on patented Co-X-Gene platform technology co-expressing antibodies and T cells.

Keywords:

australian national university, health biologics, Davies Collison Cave, AIDS, Dunhill Madden Butler, commercialisation of technology, genetics, biota, gene expression, DNA, immune response, profile, antigens, medical biotechnology, licencing, pathogen, immunobiologics, gag pol IL12, FP, psoriasis, biopharmeceutical, HIV clinical trials, HIV prophylactic trials, Australia, early stage development, FPV, development, T, gene therapy, biotechnology, CSIRO, genetic engineering, antibodies, co x gene, biologics, medical, virax, gag pol IFy, immunogenecity, patents, intellectual property, prime boost, research, alfred hospital, fowlpox virus, drugs, lymphokine, immune system, biologics technology, antisense, recombinant viral vector, fowlpox, medical biologics, platform technology, cytokines, HIV, peptech, Medical Services, gene therapy technology, IDT Australia Limited, HIV therapeutic trials, immunotherapy, health biotechnology, co expression

Contact:

A service of CYLEX Business Directory

• contact
• Print page
• Sent link
• e-mail
• Map/Routing